Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 6 Aug 20 424B5 Prospectus supplement for primary offering
- 2 Jan 20 EFFECT Notice of effectiveness
-
20 Dec 19 S-3 Shelf registration
EIGR similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Eiger BioPharmaceuticals, Inc:
We consent to the use of our report incorporated by reference herein and to the reference to our firm under the heading “Experts” in the Registration Statement and Prospectus.
/s/ KPMG LLP
San Francisco, California
December 20, 2019